Back to Search
SHAIFALI DUGAR, M.D.
M.D.
Rheumatology Physician
NPI: 1528385739IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
270125(NY)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 2004
Research & Publications (20)
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
PMID 18337095·Bioorg Med Chem Lett·2008
8-other
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
PMID 18334295·Bioorg Med Chem Lett·2008
8-other
Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
PMID 18334294·Bioorg Med Chem Lett·2008
8-other
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase.
PMID 18176091·Pharmacology·2008
7-preclinical
Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain.
PMID 18584857·Pharmacol Biochem Behav·2008
7-preclinical
p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
PMID 18056868·J Pharmacol Exp Ther·2008
4-observational
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
PMID 17522330·Neuro Oncol·2007
7-preclinical
A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
PMID 17041006·J Pharmacol Exp Ther·2007
7-preclinical
A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
PMID 16597712·J Pharmacol Exp Ther·2006
4-observational
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
PMID 16857807·Clin Cancer Res·2006
7-preclinical
Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.
PMID 16751295·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.
PMID 16707625·Mol Pharmacol·2006
8-other
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
PMID 16617327·Leukemia·2006
4-observational
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
PMID 16603672·J Pharmacol Exp Ther·2006
4-observational
Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.
PMID 15563636·Am J Respir Crit Care Med·2005
7-preclinical
p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats.
PMID 15454858·J Cardiovasc Pharmacol·2004
4-observational
Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia.
PMID 15363871·Pain·2004
4-observational
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
PMID 15289325·Cancer Res·2004
8-other
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
PMID 15183116·Biochem Pharmacol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 15 Glen St Ste 103
Glen Cove, NY 11542 - Phone
- (516) 759-0560
Quick Facts
- NPI
- 1528385739
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile